###begin article-title 0
A Novel Variable Number of Tandem Repeat of the Natriuretic Peptide Precursor B gene's 5'-Flanking Region is Associated with Essential Hypertension among Japanese Females
###end article-title 0
###begin p 1
Conflict of interest: The authors have declared that no conflict of interest exists.
###end p 1
###begin p 2
###xml 355 359 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
Background: Brain natriuretic peptide (BNP) acts primarily as a cardiac hormone; it is produced by the ventricle and has both vasodilatory and natriuretic actions. Therefore, the BNP gene is thought to be a candidate gene for essential hypertension (EH). The present study identified variants in the 5'-flanking region of natriuretic peptide precursor B (NPPB) gene and assessed the relationship between gene variants and EH.
###end p 2
###begin p 3
Methods: The polymerase chain reaction-single strand conformation polymorphism method and nucleotide sequencing were used to identify variants.
###end p 3
###begin p 4
###xml 361 369 <span type="species:ncbi:9606">patients</span>
Results: A novel variable number of tandem repeat (VNTR) polymorphism in the 5'-flanking region (-1241 nucleotides from the major transcriptional initiation site) was discovered. This VNTR polymorphism is a tandem repeat of the 4-nucleotide sequence TTTC. There were 8 alleles, ranging from 9-repeat to 19-repeat. An association study was done involving 317 EH patients and 262 age-matched normotensive (NT) subjects. The 11-repeat allele was the most frequent (88.2%); the 16-repeat allele was the second most frequent (10.5%) in the NT group. The observed and expected genotypes were in agreement with the predicted Hardy-Weinberg equilibrium values (P=0.972). Among females, the overall distribution of genotypes was significantly different between the EH and NT groups (p=0.039). The frequency of the 16-repeat allele was significantly lower in the female EH group (6.5%) than in the female NT group (12.2%, p=0.046).
###end p 4
###begin p 5
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
Conclusions: The 16-repeat allele of the VNTR in the 5'-flanking region of NPPB appears to be a useful genetic marker of EH in females.
###end p 5
###begin title 6
1. Introduction
###end title 6
###begin p 7
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
Natriuretic peptides constitute a family of three structurally related molecules: atrial natriuretic peptide (ANP) 1, brain natriuretic peptide (BNP) 2, and C-type natriuretic peptide (CNP) 3. ANP and BNP act mainly as cardiac hormones and are produced primarily by the atria and ventricles, respectively, whereas C-type natriuretic peptide is expressed mainly in the brain 4,5.
###end p 7
###begin p 8
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 439 445 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 822 823 822 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 344 359 <span type="species:ncbi:10090">Transgenic mice</span>
BNP, which was originally isolated from the porcine brain 6, shows an amino acid sequence homology to ANP. BNP has central and peripheral actions that are similar to those of ANP. The heart has the highest concentrations of BNP, and BNP acts as a cardiac hormone. Intravenous injection of BNP causes a significant decrease in blood pressure 7. Transgenic mice that overexpress BNP have a measurable reduction in blood pressure 8. Mukoyama et al. showed that plasma BNP levels are higher in individuals with essential hypertension (EH) than in normotensive (NT) individuals 7. These findings suggest that the BNP gene is a candidate gene for EH. EH is thought to be a multifactorial disorder; several studies have shown that an association analysis with genetic variants can be used to identify susceptibility genes for EH 9.
###end p 8
###begin p 9
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
The aim of the present study was to identify mutations or polymorphisms in the 5'-flanking region of the NPPB gene and to assess the relationship between variants of the gene and EH.
###end p 9
###begin title 10
2. Subjects and Methods
###end title 10
###begin title 11
Subjects
###end title 11
###begin p 12
###xml 310 311 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 1099 1101 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 30 38 <span type="species:ncbi:9606">patients</span>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
###xml 444 452 <span type="species:ncbi:9606">patients</span>
The EH group consisted of 317 patients (mean age, 49.7 +/- 7.8 years) with EH diagnosed based on sitting systolic blood pressure (SBP) greater than 160 mmHg and/or diastolic blood pressure (DBP) greater than 100 mmHg measured on three separate occasions within 2 months after the initial BP measurement (Table 1). These patients were not being treated with antihypertensive drugs. All EH subjects had a positive family history of hypertension; patients diagnosed with secondary hypertension were excluded from the study. We also enrolled 262 healthy, normotensive (NT) subjects (mean age, 51.2 +/- 10.8 years). None of the NT subjects had a family history of hypertension; all had an SBP less than 130 mmHg and a DBP less than 85 mmHg. A family history of hypertension was defined as having grandparents, uncles, aunts, parents, or siblings who had been diagnosed with hypertension. Written informed consent was obtained from each subject based on a protocol approved by the Ethics Committee of the Nihon University School of Medicine and the Clinical Studies Committee of Nihon University Hospital 10.
###end p 12
###begin title 13
Biochemical analysis
###end title 13
###begin p 14
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 261 269 <span type="species:ncbi:9606">patients</span>
Plasma total cholesterol concentrations, as well as serum creatinine and uric acid concentrations, were measured using standard methods in the Clinical Laboratory Department of Nihon University Hospital 11. Plasma BNP levels were measured in NT subjects and EH patients. A total of 76 subjects (43 in the NT group and 33 in the EH group) who did or did not have the 16 repeat allele were selected randomly. Plasma BNP levels were measured using a highly sensitive immunoradiometric assay (Shiono RIA BNP assay kit, Shionogi Co., Ltd., Tokyo, Japan) as described previously 12.
###end p 14
###begin title 15
Polymerase chain reaction - single strand conformation polymorphism (PCR-SSCP)
###end title 15
###begin p 16
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 732 739 732 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 780 787 774 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 801 808 789 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 822 829 804 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 868 875 844 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 1003 1010 973 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
Genomic DNA was extracted from peripheral blood leukocytes using a standard method 13. To screen for mutations, two oligonucleotide primers (sense, 5'- AAGGAGGCACTGGGAGAGGGGAAAT -3' (bases -1323 to -1299 from the major transcriptional initiation site) and antisense, 5'-AATTAGCTGGGCATGGTGGCAGGCG-3' (bases -1075 to -1051)) that recognize part of the 5'-flanking region of the NPPB gene were designed, since this region has been reported to be a major promoter region (Fig. 1A) 14. PCR-SSCP was done (GenePhor System; Amersham Biosciences Corp, Piscataway, NJ, USA) 15. PCR was performed using a GeneAmp PCR system 9700 (Applied Biosystems, Branchburg, NJ, USA) with the following amplification conditions: initial denaturation at 96degreesC for 3 min followed by 35 cycles of 98.5degreesC for 25 s, 65degreesC for 30 s, 68degreesC for 30 s, and a final extension of 68degreesC for 10 min. PCR products were separated by electrophoresis on 10% precast polyacrylamide gels (Amersham Biosciences Corp) at 5degreesC for 80 min and then subjected to silver staining (Dai-ichi Kagaku, Tokyo, Japan). The electrophoresis parameters were set according to the manufacturer's protocol.
###end p 16
###begin title 17
Sequencing analysis
###end title 17
###begin p 18
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 359 361 359 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
Two oligonucleotides (sense, 5'-AAGGAGGCACTGGGAGAGGGGAAAT-3' (bases -1323 to -1299) and antisense, 5'- CCCCACCAAGCCAACACAGGATGGA -3' (bases -919 to-895) were used to amplify a 429-bp product from genomic DNA (Fig. 1A). The PCR products were purified using a Microcon 100 column (U.S. Amicon Inc. Beverly, MA,USA). The resulting products were ligated to pCR2.1TM vectors and cloned (TA Cloning Kit, Invitrogen, San Diego, CA, USA). The ligation of the products was confirmed by direct DNA sequencing (ABI PRISM 310 Genetic Analyzer) 16.
###end p 18
###begin title 19
Genotyping
###end title 19
###begin p 20
###xml 143 150 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 192 199 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 215 222 203 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 236 243 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 283 290 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
###xml 415 417 385 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
Genotyping was done using fragment analysis, and the sequencing primers were used. PCR amplification consisted of an initial denaturation at 94degreesC for 3 min, followed by 35 cycles of 98.5degreesC for 25 sec, 63degreesC for 30 s, 72degreesC for 1 min, and a final extension of 72degreesC for 10 min. Then, the PCR products were analyzed using an automatic electrophoresis system (Agilent 2100 bioanalyzer systemTM; Agilent Technologies, Waldbronn, Germany).
###end p 20
###begin title 21
Statistical analysis
###end title 21
###begin p 22
###xml 107 108 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 466 468 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 481 482 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 286 294 <span type="species:ncbi:9606">patients</span>
Data are presented as the mean +/- SD. The Hardy-Weinberg equilibrium was assessed by doing chi-square (chi2) analysis. Differences in the clinical data between the EH and NT groups were assessed by analysis of variance (ANOVA). The distributions of the genotypes or alleles between EH patients and NT subjects were tested using a two-sided Fisher's exact test. Multiple logistic regression analyses were done to assess the contribution of confounders (gender, BMI) 17. A value of P < 0.05 was considered statistically significant.
###end p 22
###begin title 23
3. Results
###end title 23
###begin p 24
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
We discovered a novel variable number of tandem repeat (VNTR) polymorphism consisting of a 11-nucleotide repeat of 4 base pairs (bp) in the 5'-flanking region (-1241 nucleotides from the major transcriptional initiation site) (GenBank accession number AB265677). This VNTR polymorphism is a tandem repeat of the 4-nucleotide sequence TTTC (Fig. 1A). There were 8 alleles of this VNTR polymorphism, ranging from 9-repeat to 19-repeat (Fig. 1B).
###end p 24
###begin p 25
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
The association study showed that the 11-repeat allele was most frequent in the NT group (88.2%). The 16-repeat allele was second most frequent in the NT group (10.5%). Furthermore, in the NT group, the observed and expected genotypes were in good agreement with the predicted Hardy-Weinberg equilibrium values (P=0.972). Of note, the overall distribution of genotypes in females was significantly different between the EH and NT groups (p=0.039); the frequency of the 16-repeat allele was significantly lower in the EH group (6.5%) than in the NT group (12.2%, p=0.046) (Table 2).
###end p 25
###begin p 26
On multiple logistic regression analysis, a significant association between allele 16 (p=0.034) and female gender was noted, even after adjustment for confounding factors; the calculated odds ratio was 1.18 (95%CI: 1.07-1.20).
###end p 26
###begin p 27
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
The clinical data of each genotype were assessed. There were no significant differences in SBP and DBP levels, or in the pulse of subjects with or without the 16 repeat allele (Table 3).
###end p 27
###begin p 28
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
The plasma BNP level was significantly higher in the EH group than in the NT group (p=0.0203). The plasma BNP level in each genotype with or without the 16 repeat allele was determined (Table 4); there were no significant differences among the groups. It was impossible to perform this analysis in EH females, as none of them had the 16 repeat allele.
###end p 28
###begin p 29
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
All subjects were classified into 3 groups based on their BMI levels (lean, BMI<18.5; normal, 18.5<BMI<25; obese, BMI >25). There was no association between the genotype and the BMI among the groups (Table 5).
###end p 29
###begin title 30
4. Discussion
###end title 30
###begin p 31
###xml 6 13 6 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al. </italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
###xml 536 540 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 659 663 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
###xml 1161 1162 1161 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1537 1541 1537 1541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
###xml 1793 1797 1793 1797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
###xml 813 821 <span type="species:ncbi:9606">patients</span>
###xml 866 874 <span type="species:ncbi:9606">patients</span>
###xml 923 928 <span type="species:ncbi:9606">women</span>
###xml 940 945 <span type="species:ncbi:9606">women</span>
###xml 1006 1014 <span type="species:ncbi:9606">patients</span>
###xml 1201 1209 <span type="species:ncbi:9606">patients</span>
###xml 1668 1673 <span type="species:ncbi:9606">human</span>
Ogawa et al. reported that the 5'-flanking region of the 1.9 kilo-base pairs in the NPPB gene has a high transcriptional activity. Using the deletion mutant model, the deletion of sequences between -1288 and -1095 reduced transcriptional activity to approximately 30%. These deleted sequences contain a characteristic CT-rich region (-1248 to -1191), followed by an Alu family sequence (-1190 to -934). Thus, these results are consistent with the hypothesis that Alu repeat sequences in the 5'-flanking regions have regulatory roles in NPPB expression 14. Therefore, we assessed the association between mutations or polymorphisms in the 5'-flanking region of NPPB and the presence of EH. In the present study, a novel VNTR was discovered, and a significant association between the VNTR and EH was found in female patients. The present study found that the number of patients with a 16 repeat allele of VNTR was lower in EH women than in NT women. It is well known that the plasma BNP level is higher in EH patients than in NT subjects, since an elevated blood pressure results in a high plasma BNP level, which is one of the protective factors for hypertension 4. We compared the plasma BNP levels of patients with and without the 16 repeat allele and found that there was no significant difference between the two groups. In fact, there were not enough subjects to allow the association studies to be done by gender. Given our results, these limitations should be addressed in future studies. It is possible that factors other than the NPPB gene may have affected the BNP levels, since many factors, including cardiac function and blood pressure, are known to affect human plasma BNP levels. Thus, it is possible that the plasma BNP level is not an accurate reflection of the function of the NPPB gene.
###end p 31
###begin p 32
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 263 269 263 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> et al</italic>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 447 453 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> et al</italic>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1111 1113 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 536 541 <span type="species:ncbi:9606">women</span>
###xml 898 903 <span type="species:ncbi:9606">women</span>
In the present study, the overall distribution of the VNTR genotype and the allele frequency were significantly different in females but not in males. Gender-specific susceptibility to EH is an interesting finding, but its importance is still unclear 11. Redfield et al. reported that BNP levels increased with age, and were higher in females than males among subjects with no known cardiovascular or detectable structural heart disease 18. Maffei et al. reported that hormone replacement therapy increased BNP levels in postmenopausal women 19. Although the absolute BNP value was different between these two studies, which used two different assays, the associations of the BNP levels with age and gender were consistent. Furthermore, the BNP level that had the optimal sensitivity and specificity for detecting systolic dysfunction in the overall population increased with age and was higher in women. This underscores the clinical relevance of the relationship of age, gender, and BNP. In both studies that used different assays, the effect of gender on BNP was substantial and independent of other factors 18. Unfortunately, we were not able to obtain samples to measure plasma BNP and ANP levels, due to the difficulty in obtaining written informed consent for blood examinations from subjects not receiving medications.
###end p 32
###begin p 33
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 266 272 266 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> et al</italic>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
In the Japanese population, it has been reported that plasma BNP levels are positively associated with age, urinary salt excretion, higher blood pressure, a high R-wave voltage in the 12-lead ECG (Code 3-1 or 3-3), and female gender 20,21. On the other hand, Freitag et al., based on multivariate models adjusting for known risk factors, showed that elevated plasma BNP levels were associated with an increased risk of blood pressure progression in males but not in females. However, there was no significant trend of an increasing incidence of hypertension among BNP categories in either males or females. In a community-based sample, higher plasma BNP levels were found to be associated with an increased risk of BP progression in males, but not in females 22. Further studies are needed to resolve these conflicting results.
###end p 33
###begin p 34
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
Since there are many loci with a high degree of polymorphism in the number of tandemly repeated nucleotide sequence units, VNTR polymorphisms, also called minisatellites, were originally studied for linkage-mapping purposes. VNTRs have a highly polymorphic nature that makes them very useful as markers, both in linkage studies to map disease loci in families and in forensic applications. Recent reports indicate that some VNTR sequences may function as transcriptional or translational regulators, and that they may modify the function of a protein when the tandemly repeated region lies within the coding region of the gene 23. Although no clear effect on transcription has been shown, it has been reported that a VNTR in the second intron of the serotonin transporter gene is associated with susceptibility to major depression 24.
###end p 34
###begin p 35
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 56 61 <span type="species:ncbi:9606">human</span>
We previously determined the structural organization of human natriuretic peptide receptor genes 25-28 and identified an insertion/deletion mutation in the 5'-untranslated region of NPRA 12. The deletion encompasses eight nucleotides and alters the binding sites for the AP2 and zeste transcription factors. Transcriptional activity of the deletion allele was less than 30% that of the wild-type allele. The deletion allele was significantly more common in the EH group than in the NT group. These findings suggest that in Japanese individuals, this deletion in the NPRA gene reduces receptor activity and may confer increased susceptibility for the individual to develop EH or left ventricular hypertrophy (LVH). Animal models with a deletion of this gene develop disorders that resemble the symptoms of subjects with a deleted allele in the 5'-untranslated region of NPRA. We previously isolated a missense mutation of the NPRA gene 29 and a VNTR polymorphism upstream of the NPRC gene; this VNTR influences blood pressure levels in obesity-associated hypertension 30. Since the sampling of the above reports was different from the present experiment, it was impossible to analyze the relationship between systemic natriuretic peptide genes and EH.
###end p 35
###begin p 36
###xml 5 11 5 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
Wang et al. reported that obese individuals have low circulating natriuretic peptide levels, which may contribute to their susceptibility to hypertension and hypertension-related disorders. The mechanisms linking obesity to hypertension have not been established, but sodium retention and excessive sympathetic tone are key contributors. Natriuretic peptides are important regulators of sodium homeostasis and neurohormonal activation; this raises the possibility that obese individuals have an impaired natriuretic peptide response 31. Therefore, we examined the relationship between the genotype and BMI and found no significant association.
###end p 36
###begin p 37
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
In conclusion, a novel VNTR in the 5'-flanking region of the NPPB gene was discovered. This polymorphism was associated with EH in female subjects. However, this finding does not necessarily imply that there is a relationship between the NPPB gene and EH. Further studies of other polymorphisms are needed to determine whether there is an association between the NPPB gene and EH.
###end p 37
###begin p 38
We would like to thank Dr. Y. Watanabe and Dr. Y. Izumi for collecting the samples, and Ms. H. Tobe, M. Nakamura, and K. Sugama for their technical assistance. This work was supported financially by a grant from the Ministry of Education, Science and Culture of Japan (High-Tech Research Center, Nihon University).
###end p 38
###begin article-title 39
###xml 55 60 <span type="species:ncbi:9606">human</span>
Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)
###end article-title 39
###begin article-title 40
A new natriuretic peptide in porcine brain
###end article-title 40
###begin article-title 41
C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain
###end article-title 41
###begin article-title 42
Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides
###end article-title 42
###begin article-title 43
Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system"
###end article-title 43
###begin article-title 44
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Cardiac fibrosis in mice lacking brain natriuretic peptide
###end article-title 44
###begin article-title 45
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human brain natriuretic peptide, a novel cardiac hormone
###end article-title 45
###begin article-title 46
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
###xml 114 129 <span type="species:ncbi:10090">transgenic mice</span>
Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene
###end article-title 46
###begin article-title 47
###xml 19 24 <span type="species:ncbi:9606">human</span>
Molecular basis of human hypertension: role of angiotensinogen
###end article-title 47
###begin article-title 48
An association study in essential hypertension using functional polymorphisms in lymphotoxin-alpha gene
###end article-title 48
###begin article-title 49
The association study of calcitonin-receptor-like receptor gene in essential hypertension
###end article-title 49
###begin article-title 50
###xml 65 70 <span type="species:ncbi:9606">human</span>
Functional deletion mutation of the 5'-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese
###end article-title 50
###begin article-title 51
Isolation of the 5'-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction
###end article-title 51
###begin article-title 52
###xml 77 82 <span type="species:ncbi:9606">human</span>
Characterization of the 5'-flanking region and chromosomal assignment of the human brain natriuretic peptide gene
###end article-title 52
###begin article-title 53
Association of 5' upstream promoter region of prostacyclin synthase gene variant with cerebral infarction
###end article-title 53
###begin article-title 54
Association study between C reactive protein (CRP) genes and ischemic stroke in Japanese subjects
###end article-title 54
###begin article-title 55
The association between the calcitonin-related peptide alpha (CALCA) gene and essential hypertension in Japanese subjects
###end article-title 55
###begin article-title 56
Plasma brain natriuretic peptide concentration: impact of age and gender
###end article-title 56
###begin article-title 57
###xml 115 120 <span type="species:ncbi:9606">women</span>
Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women
###end article-title 57
###begin article-title 58
What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population?
###end article-title 58
###begin article-title 59
Greater change of orthostatic blood pressure is related to silent cerebral infarct and cardiac overload in hypertensive subjects
###end article-title 59
###begin article-title 60
Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study
###end article-title 60
###begin article-title 61
VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators
###end article-title 61
###begin article-title 62
Polymorphism in serotonin transporter gene associated with susceptibility to major depression
###end article-title 62
###begin article-title 63
###xml 60 65 <span type="species:ncbi:9606">human</span>
Nucleotide sequence of the 5'-flanking region of the type A human natriuretic peptide receptor gene and association analysis using a novel microsatellite in essential hypertension
###end article-title 63
###begin article-title 64
###xml 20 25 <span type="species:ncbi:9606">human</span>
Organization of the human natriuretic peptide receptor A gene
###end article-title 64
###begin article-title 65
###xml 24 29 <span type="species:ncbi:9606">human</span>
Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension
###end article-title 65
###begin article-title 66
###xml 35 40 <span type="species:ncbi:9606">human</span>
Structure and polymorphisms of the human natriuretic peptide receptor C gene
###end article-title 66
###begin article-title 67
###xml 50 55 <span type="species:ncbi:9606">human</span>
A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: possible association with essential hypertension
###end article-title 67
###begin article-title 68
###xml 69 74 <span type="species:ncbi:9606">human</span>
Variable number of tandem repeat of the 5'-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension
###end article-title 68
###begin article-title 69
Impact of obesity on plasma natriuretic peptide levels
###end article-title 69
###begin title 70
Figures and Tables
###end title 70
###begin p 71
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NPPB</italic>
###xml 185 200 185 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">closed triangle</italic>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Boxe</italic>
###xml 234 253 234 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">double underlining,</italic>
###xml 293 304 293 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">overlining,</italic>
###xml 327 339 327 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Underlining,</italic>
###xml 461 462 461 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 56 61 <span type="species:ncbi:9606">human</span>
A: Nucleotide sequence of the 5'-flanking region of the human NPPB gene. The nucleotide sequences are numbered (left) with respect to the major transcription start site (designated +1; closed triangle). Boxes, the primers (PCR-SSCP); double underlining, the primers (sequence and genotyping); overlining, ATG initiation codon; Underlining, the variable number of tandem repeat (VNTR) consists of the 4 nucleotides (TTTC). This figure shows the 11 repeat types. B: Nucleotide sequence of the 11 and 16 repeat allele.
###end p 71
###begin p 72
###xml 25 37 <span type="species:ncbi:9606">participants</span>
Characteristics of study participants
###end p 72
###begin p 73
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Genotype distribution in NT subjects and EH patients
###end p 73
###begin p 74
The association between genotype and phenotype
###end p 74
###begin p 75
###xml 22 30 <span type="species:ncbi:9606">patients</span>
Plasma BNP levels for patients with or without 16 repeat
###end p 75
###begin p 76
Distribution of subjects by BMI
###end p 76

